These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6194777)

  • 1. Systemic interferon therapy for multiple sclerosis. Design of a trial.
    Johnson KP
    Arch Neurol; 1983 Oct; 40(11):681-2. PubMed ID: 6194777
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferons and multiple sclerosis.
    Clanet M; Blancher A; Calvas P; Rascol O
    Biomed Pharmacother; 1989; 43(5):355-60. PubMed ID: 2477075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of natural alpha interferon in multiple sclerosis.
    Knobler RL; Panitch HS; Braheny SL; Sipe JC; Rice GP; Huddlestone JR; Francis GS; Hooper CJ; Kamin-Lewis RM; Johnson KP
    Ann N Y Acad Sci; 1984; 436():382-8. PubMed ID: 6398020
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis.
    Camenga DL; Johnson KP; Alter M; Engelhardt CD; Fishman PS; Greenstein JI; Haley AS; Hirsch RL; Kleiner JE; Kofie VY
    Arch Neurol; 1986 Dec; 43(12):1239-46. PubMed ID: 3535752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study.
    Jacobs L; O'Malley JA; Freeman A; Reese P
    Arch Neurol; 1983 Oct; 40(11):683-6. PubMed ID: 6354150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results].
    Huber M
    Nervenarzt; 1988 Sep; 59(9):514-20. PubMed ID: 2460777
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon in multiple sclerosis.
    Hendel DL; Hart LL
    DICP; 1990 Feb; 24(2):158-60. PubMed ID: 1689920
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal interferon for multiple sclerosis.
    Berry CC
    Science; 1982 Jul; 217(4556):269-70. PubMed ID: 6178161
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug Insight: interferon treatment in multiple sclerosis.
    Marrie RA; Rudick RA
    Nat Clin Pract Neurol; 2006 Jan; 2(1):34-44. PubMed ID: 16932519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal beta-interferon in multiple sclerosis.
    Milanese C; Salmaggi A; la Mantia L; Corridori F; Nespolo A
    Lancet; 1988 Sep; 2(8610):563-4. PubMed ID: 2900935
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.
    Hertz F; Deghenghi R
    Agents Actions; 1985 Jul; 16(5):397-403. PubMed ID: 2413742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic alpha-interferon in multiple sclerosis. Long-term patient follow-up.
    Panitch HS
    Arch Neurol; 1987 Jan; 44(1):61-3. PubMed ID: 3800723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal interferon, indomethacin, and multiple sclerosis.
    Berenbaum MC
    Lancet; 1987 Feb; 1(8528):326-7. PubMed ID: 2880135
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis.
    Abb J; Deinhardt F; Zander H; Tenser RB; Rapp F; Goust JM; Fudenberg HH; Vilcek J; Ho M; Merigan TC; Oldstone MB; Jackson GG
    J Infect Dis; 1982 Jul; 146(1):109-15. PubMed ID: 6177805
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic interferon therapy of multiple sclerosis: the pros.
    Knobler RL
    Neurology; 1988 Jul; 38(7 Suppl 2):58-61. PubMed ID: 3133575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief history of the use of interferons as treatment of multiple sclerosis.
    Jacobs L; Johnson KP
    Arch Neurol; 1994 Dec; 51(12):1245-52. PubMed ID: 7986181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New hope for multiple sclerosis victims via an improved, inexpensive, orthomolecular, interferon clinical protocol.
    Stone I
    Australas Nurses J; 1982 Apr; 11(3):13-5. PubMed ID: 6180724
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferons and cancer: how the promise is being kept.
    Borden EC
    Interferon; 1983; 5():43-83. PubMed ID: 6202643
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation.
    Kastrukoff LF; Oger JJ; Hashimoto SA; Sacks SL; Li DK; Palmer MR; Koopmans RA; Petkau AJ; Berkowitz J; Paty DW
    Neurology; 1990 Mar; 40(3 Pt 1):479-86. PubMed ID: 2179764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.